Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Songge Jiang Niaosuan granules is a Traditional Chinese Medicine (TCM) formulation developed by Zhejiang Chinese Medical University for the treatment of hyperuricemia. It is specifically designed for patients presenting with TCM patterns of phlegm-dampness obstruction or internal damp-heat. The formulation aims to lower serum uric acid levels and has been evaluated in Phase 2 clinical trials (e.g., CTR20192025) to assess its efficacy and safety in adult patients. As a TCM product, it likely consists of a combination of botanical extracts intended to modulate uric acid metabolism and excretion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Songge Jiang Niaosuan granules.